EFFECTS OF DIPEPTIDYL PEPTIDASE-4 INHIBITORS ON LEFT VENTRICULAR REVERSE REMODELING IN PATIENTS WITH DIABETES MELLITUS AND HEART FAILURE  by Okino, Shinichi & Fukuzawa, Shigeru
Heart Failure and Cardiomyopathies
A858
JACC March 17, 2015
Volume 65, Issue 10S
effects of dIPePtIdyl PePtIdAse-4 InhIBItors on left ventrIculAr reverse 
remodelIng In PAtIents wIth dIABetes mellItus And heArt fAIlure
Poster Contributions
Poster Hall B1
Saturday, March 14, 2015, 3:45 p.m.-4:30 p.m.
Session Title: Novel Therapies for Heart Failure
Abstract Category: 15.  Heart Failure and Cardiomyopathies: Therapy
Presentation Number: 1145-188
Authors: Shinichi Okino, Shigeru Fukuzawa, Funabashi Municipal Medical Center, Funabashi, Japan
Background: It is uncertain whether dipeptidyl peptidase-4 inhibitor (DPP4i) therapy improves left ventricular (LV) remodeling in patients 
with diabetes mellitus (DM) and heart failure (HF). This study investigated effects of DPP4i on LV reverse remodeling in patients with DM 
and HF.
methods: Patients with DM who were hospitalized due to worsening HF were enrolled (n=210, DPP4i = 51, non-DPP4i = 159). LV ejection 
fraction (LVEF), end-systolic (LVESV) and end-diastolic volume (LVEDV) and LV mass (LVM) at baseline and follow-up (more than six 
months later) were assessed by echocardiography. LV reverse remodeling was defined as >15% increase of LVEF and >15% reduction of 
LVESV. LV reverse remodeling was compared in crude and propensity score-matched analyses.
results: Baseline echocardiographic characteristics did not differ between DPP4i and non-DPP4i patients. LVEF, LVESV and LVM 
were more improved in DPP4i patients than in non-DPP4i patients (follow-up/baseline ratio of LVEF: 1.37 +/- 0.54 vs. 1.19 +/- 0.45, 
p=0.018; LVESV: 0.81 +/- 0.46 vs. 0.97 +/- 0.41, p=0.019; LVM: 0.87 +/- 0.17 vs. 0.96 +/- 0.18, p=0.004) (Figure), Multivariate analysis 
showed DPP4i was an independent predictor of LV reverse remodeling (odds ratio [OR] 2.663, 95% confidence interval [CI] 1.234 to 
5.747, p=0.013), which was corroborated by a similar result from the propensity score-matched cohort (OR 3.218, 95%CI 1.227 to 8.440, 
p=0.018).
conclusion:  DPP4i was associated with LV reverse remodeling in patients with DM and HF.
 
